The potential role of estrogen in aromatase regulation in the breastWEI YUE; BERSTEIN, Lev M; WANG, Ji-Ping et al.Journal of steroid biochemistry and molecular biology. 2001, Vol 79, Num 1-5, pp 157-164, issn 0960-0760Conference Paper

Molecular heterogeneity of inflammatory breast cancer : A hyperproliferative phenotypeNGUYEN, Dang M; SAM, Kathy; O'CONNELL, Peter et al.Clinical cancer research. 2006, Vol 12, Num 17, pp 5047-5054, issn 1078-0432, 8 p.Article

Estrogen-related receptor α and estrogen-related receptor γ associate with unfavorable and favorable biomarkers, respectively, in human breast cancersARIAZI, Eric A; CLARK, Gary M; MERTZ, Janet E et al.Cancer research (Baltimore). 2002, Vol 62, Num 22, pp 6510-6518, issn 0008-5472, 9 p.Article

A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with advanced solid malignanciesSIU, Lillian L; ROWINSKY, Eric K; SKLENAR, Ivo T et al.Clinical cancer research. 2002, Vol 8, Num 7, pp 2157-2166, issn 1078-0432Article

HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancerTOWNSON, Steven M; SULLIVAN, Toby; ZHANG, QingPing et al.Clinical cancer research. 2000, Vol 6, Num 9, pp 3788-3796, issn 1078-0432Article

Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapiesMARTIN, Michelle D; HILSENBECK, Susan G; MOHSIN, Syed K et al.Breast cancer research and treatment. 2006, Vol 95, Num 1, pp 7-12, issn 0167-6806, 6 p.Article

Effects of smoking on the pharmacokinetics of erlotinibHAMILTON, Marta; WOLF, Julie L; RUSK, Jason et al.Clinical cancer research. 2006, Vol 12, Num 7, pp 2166-2171, issn 1078-0432, 6 p., 1Article

Determinants of tumor Response and survival with erlotinib in patients with non-small-cell lung CancerPEREZ-SOLER, Roman; CHACHOUA, Abraham; HAMMOND, Lisa A et al.Journal of clinical oncology. 2004, Vol 22, Num 16, pp 3238-3247, issn 0732-183X, 10 p.Article

Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databasesBARDOU, Valerie-Jeanne; ARPINO, Grazia; ELLEDGE, Richard M et al.Journal of clinical oncology. 2003, Vol 21, Num 10, pp 1973-1979, issn 0732-183X, 7 p.Article

Neurosensory differences after wire and Rigid fixation in patients with mandibular advancement. DiscussionLEMKE, Robert R; RUGH, John D; VAN SICKELS, Joseph et al.Journal of oral and maxillofacial surgery. 2000, Vol 58, Num 12, pp 1354-1360, issn 0278-2391Article

Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignanciesECKHARDT, S. Gail; BAKER, Sharyn D; CLARK, Gary M et al.Journal of clinical oncology. 2000, Vol 18, Num 24, pp 4086-4097, issn 0732-183XArticle

Hazard rates of recurrence following diagnosis of primary breast cancerJATOI, Ismail; TSIMELZON, Anna; WEISS, Heidi et al.Breast cancer research and treatment. 2005, Vol 89, Num 2, pp 173-178, issn 0167-6806, 6 p.Article

Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast cancerMOHSIN, Syed K; ALLRED, D. Craig; OSBORNE, C. Kent et al.Breast cancer research and treatment. 2005, Vol 94, Num 3, pp 205-211, issn 0167-6806, 7 p.Article

Estrogen receptor β protein in human breast cancer : Correlation with clinical parametersFUQUA, Suzanne A. W; SCHIFF, Rachel; PARRA, Irma et al.Cancer research (Baltimore). 2003, Vol 63, Num 10, pp 2434-2439, issn 0008-5472, 6 p.Article

Maspin expression in invasive breast cancer: association with other prognostic factorsMOHSIN, Syed K; MING ZHANG; CLARK, Gary M et al.Journal of pathology. 2003, Vol 199, Num 4, pp 432-435, issn 0022-3417, 4 p.Article

Survival of patients with metastatic breast carcinoma: Importance of prognostic markers of the primary tumorCHANG, Jenny; CLARK, Gary M; ALLRED, D. Craig et al.Cancer. 2003, Vol 97, Num 3, pp 545-553, issn 0008-543X, 9 p.Article

Adenoid cystic carcinoma of the breast: Molecular markers, treatment, and clinical outcomeARPINO, Grazia; CLARK, Gary M; MOHSIN, Syed et al.Cancer. 2002, Vol 94, Num 8, pp 2119-2127, issn 0008-543XArticle

Erlotinib for Advanced Non-Small-Cell Lung Cancer in the Elderly : An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21WHEATLEY-PRICE, Paul; DING, Keyue; SEYMOUR, Lesley et al.Journal of clinical oncology. 2008, Vol 26, Num 14, pp 2350-2357, issn 0732-183X, 8 p.Article

REporting recommendations for tumor MARKer prognostic studies (REMARK)MCSHANE, Lisa M; ALTMAN, Douglas G; SAUERBREI, Willi et al.Breast cancer research and treatment. 2006, Vol 100, Num 2, pp 229-235, issn 0167-6806, 7 p.Article

REporting recommendations for tumour MARKer prognostic studies (REMARK)MCSHANE, Lisa M; ALTMAN, Douglas G; SAUERBREI, Willi et al.European journal of cancer (1990). 2005, Vol 41, Num 12, pp 1690-1696, issn 0959-8049, 7 p.Article

Reporting recommendations for tumor marker prognostic studiesMCSHANE, Lisa M; ALTMAN, Douglas G; SAUERBREI, Willi et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9067-9072, issn 0732-183X, 6 p.Article

Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomasRAYMOND, Eric; FAIVRE, Sandrine; WEISS, Geoffrey et al.Clinical cancer research. 2001, Vol 7, Num 5, pp 1171-1180, issn 1078-0432Article

Comment on : Tumor characteristics and clinical outcome of elderly women with breast cancer. Authors' replyBASCHE, Michele; BYERS, Tim; WEISS, Noel S et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 1, pp 64-66, issn 0027-8874Article